Skip to main content
SpringerLink
Log in

Merck settles Vioxx lawsuits for $4.85 billion

  • News
  • Published:

From Nature

View current issue Submit your manuscript

But drug firm maintains it was not at fault over arthritis drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Meredith Wadman
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Cardiovascular Medicine

Related external links

Merck news release detailing Vioxx settlement

Lanier Law firm news release on Vioxx settlement

Garret FitzGerald, Chair, Department of Pharmacology, University of Pennsylvania

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman, M. Merck settles Vioxx lawsuits for $4.85 billion. Nature (2007). https://doi.org/10.1038/450324b

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/450324b

  • Springer Nature Limited

Search

Navigation